TFEB and synucleinopathy: Here, we demonstrate that targeting neuronal expression of TFEB was sufficient to reduce synucleinopathy and prevent neurodegeneration in the A53T–α-syn rat model of PD, while only oligodendroglial overexpression of TFEB leads to neuroprotective effects in the MSA mouse model (Supplemental Figure 5).